80 results
8-K
EX-1.1
AQST
Aquestive Therapeutics Inc
21 Mar 24
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
, enforcement, investigation, arbitration or other action from any governmental authority, including, without limitation, the FDA or the United States … claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court, arbitrator, Regulatory Agency
8-K
EX-10.2
AQST
Aquestive Therapeutics Inc
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
, regardless of any investigation made by any Secured Party or on its behalf and notwithstanding that the Collateral Agent, the Trustee or any other Secured … BY ANY SUCH PERSON UNDER OR IN CONNECTION WITH ANY OF THE FOREGOING, INCLUDING WITH RESPECT TO ANY INVESTIGATION, LITIGATION, OR PROCEEDING (INCLUDING
8-K
EX-10.1
exsriuan
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-4.1
cleta548rns
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.3
x3quhlo3m
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-4.1
ub4rwwc
2 Aug 23
Entry into a Material Definitive Agreement
8:22am
8-K
EX-1.1
wzj5wa7ptn ky
8 Jun 22
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
4:22pm
8-K
EX-10.1
yt0hp6t0ajssfywx
8 Jun 22
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
4:22pm
8-K
EX-10.1
ykm81ic csit
17 May 22
Aquestive Therapeutics Announces CEO Transition
4:10pm